| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |